Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red de Cáncer (8)

2023

  1. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer

    Frontiers in Immunology, Vol. 14

  2. New proposal to address mediation analysis interrogations by using genetic variants as instrumental variables

    Genetic Epidemiology, Vol. 47, Núm. 3, pp. 287-300

2022

  1. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

  2. Avoiding collider bias in Mendelian randomization when performing stratified analyses

    European Journal of Epidemiology, Vol. 37, Núm. 7, pp. 671-682

  3. Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials

    ESMO Open, Vol. 7, Núm. 3

2020

  1. Immunohistochemistry-based taxonomical classification of bladder cancer predicts response to neoadjuvant chemotherapy

    Cancers, Vol. 12, Núm. 7, pp. 1-13

2019

  1. CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis

    Bladder Cancer, Vol. 5, Núm. 2, pp. 159-169

2018

  1. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

    European Respiratory Journal